Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components
- 31 October 2001
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 38, 34-45
- https://doi.org/10.1016/s0037-1963(01)90122-2
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Graft-versus-host disease: The influence of type 1 and type 2 T cell cytokinesTransfusion Medicine Reviews, 1998
- Characterization of T-Cell Clones Derived From Peripheral Blood Lymphocytes of a Patient With Transfusion-Associated Graft-Versus-Host Disease: Fas-Mediated Killing by CD4+ and CD8+ Cytotoxic T-Cell Clones and Tumor Necrosis Factor β Production by CD4+ T-Cell ClonesBlood, 1997
- Survey of transfusion-associated graft-versus-host disease in immunocompetent recipientsTransfusion Medicine Reviews, 1996
- Immune responses to major histocompatibility complex homozygous lymphoid cells in murine F1 hybrid recipients: implications for transfusion-associated graft-versus-host diseaseBlood, 1995
- Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase.The Journal of Experimental Medicine, 1995
- Transfusion‐associated graft‐versus‐host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second‐degree relative, and a survey of predisposing factorsTransfusion, 1993
- HLA Homozygosity and the Risk of Related-Donor Transfusion-Associated Graft-Versus-Host DiseaseTransfusion Medicine Reviews, 1993
- Transfusion-Associated Graft-Versus-Host Disease and Blood IrradiationTransfusion Medicine Reviews, 1992
- Erythropoietin for the Treatment of Porphyria Cutanea Tarda in a Patient on Long-Term HemodialysisNew England Journal of Medicine, 1990
- Graft-versus-host reaction following blood product transfusionThe American Journal of Medicine, 1982